Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
European Journal of Cancer (Oxford, England : 1990)|February 20, 2026
Comparative effectiveness of first-line anti-PD-1 versus cetuximab in advanced cutaneous squamous cell carcinoma: A nationwide population-based study using the French national health data systemQuentin Samaran, Thomas Bettuzzi, Emilie Sbidian
Journal of Medical Virology|March 22, 2025
Modern Approach to Manage Patients With Kaposi SarcomaThomas Bettuzzi, Celeste Lebbe, Chloé Grolleau
The Journal of Antimicrobial Chemotherapy|November 3, 2025
Differences in prescription for impetigo and cellulitis across years in three European countriesThomas Bettuzzi, Christophe Strady, Sylvain Diamantis, et al.
Therapie|November 18, 2023
Cutaneous adverse drug reactionsThomas Bettuzzi, Paola Sanchez-Pena, Bénédicte Lebrun-Vignes
JAMA Dermatology|October 2, 2024
Incidence, In-Hospital and Long-Term Mortality, and Sequelae of Epidermal Necrolysis in AdultsThomas Bettuzzi, Bénédicte Lebrun-Vignes, Saskia Ingen-Housz-Oro, et al.
Clinical and Experimental Dermatology|January 6, 2025
Recurrences and rechallenges of suspected drugs in patients with epidermal necrolysisThomas Bettuzzi, Bénédicte Lebrun-Vignes, Haudrey Assier, et al.
Pharmacoepidemiology and Drug Safety|December 15, 2021
Biases associated with epidermal necrolysis reporting in pharmacovigilance: An exploratory analysis using World Health Organization VigiBaseThomas Bettuzzi, Saskia Ingen-Housz-Oro, Patrick Maison, et al.
The British Journal of Dermatology|December 2, 2021
Overlapping network meta-analyses on psoriasis systemic treatments, an overview: quantity does not make qualityRobin Guelimi, Sivem Afach, Jean Philippe Régnaux, et al.
The British Journal of Dermatology|June 7, 2024
Comparison of incidence, causes and prognosis of adult and paediatric epidermal necrolysis: a French population-based studyThomas Bettuzzi, Anne Welfringer-Morin, Saskia Ingen-Housz-Oro, et al.
Journal of Clinical Epidemiology|June 9, 2024
Funding and conclusions of network meta-analyses on targeted therapies in inflammatory diseases: an overviewRobin Guelimi, Sivem Afach, Thomas Bettuzzi, et al.
Pageof 3